RE:Press Release That will definitely help, but I think we could also get some movement on big QAPs partnership announcements, which are coming. The initial FDA approval to release the next $2M US payment may help and is likely within this fiscal year, but with the lukewarm response to the deal itself I think that's unlikely. These little new product announcements are all good for the long term but nobody is paying attention at all. I make myself feel better by reviewing all the Kinlytic deal details and what that will mean in the future while everyone else worries about lack of VTM sales today, one will dwarf the other and be a historical footnote that nobody remembers.